Filing Details

Accession Number:
0001179110-17-004785
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-17 11:53:24
Reporting Period:
2017-03-15
Filing Date:
2017-03-17
Accepted Time:
2017-03-17 11:53:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1650664 Editas Medicine Inc. EDIT Biological Products, (No Disgnostic Substances) (2836) 464097528
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658390 Alexandra Glucksmann C/O Editas Medicine, Inc.
11 Hurley St.
Cambridge MA 02141
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-15 1,000 $0.65 118,788 No 4 M Direct
Common Stock Disposition 2017-03-15 1,000 $26.41 117,788 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-03-15 1,000 $0.00 1,000 $0.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,461 2025-04-14 No 4 M Direct
Footnotes
  1. The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016.
  2. This option was granted on April 16, 2015 and is scheduled to vest over four years with 25% of the shares having vested on March 9, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through March 9, 2019.